Who owns CYTOMED THERAPEUTICS LIMITED?
- Ticker: GDTC
- CUSIP Number: y1r80m106
Tip: Access positions for across all investors
Analyze quarterly positions in Cytomed Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cytomed Therapeutics stock
Who bought or sold CYTOMED THERAPEUTICS LIMITED this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Susquehanna International | 30k | $40k | 100% | Dec 2025 |
|
| Two Sigma Securities | 12k | $16k | 100% | Dec 2025 |
|
| Intl Fcstone | 10k | $14k | 100% | Dec 2025 |
|
| UBS Group | 1.1k | $1.4k | -92% | Dec 2025 |
|
| Advisor Group Holdings | 21.00 | $27.999300 | 100% | Dec 2025 |
|
Who sold out of Cytomed Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Sontag Advisory | Sep 2025 | 4.8k | $9.6k |